Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma
- 1 December 2022
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 78 (3) , 627-642
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (22074108, 32270643, 81870427, 91957109)
This publication has 35 references indexed in Scilit:
- Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue MetabolomicsCancer Research, 2013
- Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical ApplicationPharmacological Reviews, 2012
- AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathwaysHepatology, 2011
- 3‐Hydroxyisobutyrate aciduria and mutations in the ALDH6A1 gene coding for methylmalonate semialdehyde dehydrogenaseJournal of Inherited Metabolic Disease, 2011
- Coactivation of AKT and β-Catenin in Mice Rapidly Induces Formation of Lipogenic Liver TumorsCancer Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular CarcinomaCancer Research, 2009
- Experimental mouse models for hepatocellular carcinoma researchInternational Journal of Experimental Pathology, 2009
- Assessing the Reversibility of the Anaplerotic Reactions of the Propionyl-CoA Pathway in Heart and LiverJournal of Biological Chemistry, 2003
- Interorgan metabolism of valineAmino Acids, 1991